Publications by authors named "A Galassi"

Aims: Knowledge of the effects of sex in cardio-oncology is limited, particularly in patients treated with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukaemia (CML). This study aims to evaluate the influence of gender differences on the incidence of cardiovascular toxicity in patients with CML.

Methods: The study population consisted of 148 patients (45% women, mean age: 58 ± 14.

View Article and Find Full Text PDF

Background: The parallel wire technique (PW) is a classic part of the antegrade strategy to open chronic total coronary occlusions (CTO).

Aims: With modern wires and dual-lumen catheters (DLC) the approach has evolved, but this progress had not been evaluated in a contemporary registry of CTO interventions.

Method: This analysis is based on 26,589 CTO procedures performed by 36 operators with > 50 procedures annually between 2015 and 2022.

View Article and Find Full Text PDF

Infectious catheter-related right atrial thrombus (CRAT) is a potentially fatal but often underestimated contingency associated with central venous catheter (CVC) in patients on hemodialysis. Management guidelines for CRAT are lacking, and its occurrence poses clinical challenges. Here, we describe the case of an infectious CRAT in a young patient on hemodialysis with peculiar clinical complications and perform a literature review.

View Article and Find Full Text PDF

Our laboratory recently developed [C]PS13 as a PET radioligand to selectively measure cyclooxygenase-1 (COX-1). The cyclooxygenase enzyme family converts arachidonic acid into prostaglandins and thromboxanes, which mediate inflammation. The total brain uptake of [C]PS13, which is composed of both specific binding and background uptake, can be accurately quantified with gold standard methods of compartmental modeling.

View Article and Find Full Text PDF
Article Synopsis
  • Advances in cancer treatment have led to more cancer survivors, increasing the incidence of both adult and childhood cancer survivors.
  • However, survivors treated with certain therapies, like anthracyclines and radiation, face a heightened risk of long-term cardiovascular issues, including heart failure and coronary artery diseases.
  • It’s crucial to assess cardiovascular risk after cancer therapy and implement long-term monitoring and preventive strategies in alignment with current guidelines to manage potential late complications.
View Article and Find Full Text PDF